It has been reported that both MT1-MMP and membrane type 3 matrix metalloproteinase (MT3-MMP) modulate pro-MMP-2 activation, whose angiogenic role in cancer was mentioned above, through inhibition by TIMP-2 and TIMP-3 (151). This evidence concerns the gene MMP16 and cancer.